FirstWord Pharma
@fwpharma
Followers
55,467
Following
620
Media
1,452
Statuses
37,439
The latest global #pharma news, insights, analysis, and views providing you with an information edge. FirstWord Pharma. Where people who know first, go first.
Joined April 2009
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
برشلونة
• 756079 Tweets
ليفركوزن
• 745184 Tweets
BRICS
• 542847 Tweets
John Kelly
• 219631 Tweets
Atlantic
• 214836 Tweets
Trump is Hitler
• 141912 Tweets
Pegasus
• 131427 Tweets
ILL BE THERE MV TEASER
• 130505 Tweets
Bayern
• 120457 Tweets
#tusaş
• 111370 Tweets
#BlackOps6
• 69850 Tweets
Peñarol
• 49883 Tweets
Hopkins
• 48814 Tweets
#6GoldenYearsWithATEEZ
• 45155 Tweets
#편도행_해적선_6년째_순항중
• 43989 Tweets
Türk Havacılık
• 42897 Tweets
Şehitlerimize Allah'tan
• 38212 Tweets
Botafogo
• 33177 Tweets
Rio de Janeiro
• 21504 Tweets
Fallout
• 17174 Tweets
Recreio
• 15962 Tweets
Varela
• 15449 Tweets
Kilmeade
• 14567 Tweets
Turkish Aerospace Industries
• 13461 Tweets
Brest
• 11481 Tweets
INBA
• 10396 Tweets
ワイルズ
• 10357 Tweets
EMA committee backs approval of Orexigen's
#obesity
therapy Mysimba
http://t.co/6ghKgRhNKP
$OREX
#pharma
0
18
143
BREAKING NEWS: FDA approves Biogen, Eisai's Alzheimer's therapy Aduhelm $BIIB
1
22
36
Everyday pressures on HCPs are coupled with the struggle to stay up-to-date on medical information. Alongside
@elsevierpharma1
, we asked 7 experts about the need for trusted
#clinicalcontent
. Watch now:
#rethinkingclinicalcontent
#firstwordperspectives
#ad
5
3
20
FDA approves trial of Roche's Actemra for hospitalised patients with severe COVID-19 pneumonia
1
15
15
BREAKING NEWS: Eli Lilly to buy Loxo Oncology for $8 billion $LLY $LOXO
0
10
14
AbbVie's Rinvoq tops Dupixent in head-to-head atopic dermatitis trial $ABBV $REGN $SNY
0
1
12
#Pharma
's 20 largest pipeline drugs are forecast to generate sales of $40 billion by 2020
http://t.co/UGsK3ThndA
http://t.co/LPGlgoEbLr
0
15
12
Samsung Biologics mulling opportunities in cell, gene therapy: report
1
3
12
2
20
12
Astellas says late-stage study of roxadustat in chronic kidney disease patients with anaemia hits main goals $FGEN
0
4
11
FirstWord Lists – The best selling drugs in 2014
http://t.co/nSok4bn36W
#pharma
#biotech
http://t.co/RgHkejKATJ
0
17
11
Pfizer to provide all patented drugs, vaccines to poor countries on no-profit basis $PFE
1
2
11
EU approves Novartis' CAR-T cell therapy Kymriah for blood cancers
0
7
10
J&J, Legend's CAR-T therapy Carvykti cleared in Europe $JNJ $LEGN
0
2
8
BREAKING NEWS:
Lilly's donanemab slows cognitive decline in key Alzheimer's study $LLY
0
4
11
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline - PR $MRK
0
4
11
Merck & Co. halts development of HIV drug after drop in immune cell counts $MRK
0
2
9
BREAKING NEWS: AstraZeneca to buy Alexion for $39 billion $AZN $ALXN
0
5
10
FDA panel narrowly backs approval of Sarepta's DMD gene therapy $SRPT
0
2
4
BREAKING NEWS: Novartis CEO Joseph Jimenez to retire next year; Vasant Narasimhan named as replacement $NVS
0
6
9
Pfizer, BioNTech's mRNA-based COVID-19 vaccine shows potential in early study
0
2
10
NHS England reaches deal to make Gilead's CAR-T cell therapy Yescarta available via Cancer Drugs Fund $GILD
1
8
10
BREAKING NEWS: BMS to buy MyoKardia for $13.1 billion $BMY $MYOK
0
4
9
FDA clears Otsuka's Abilify MyCite as first drug in US with digital ingestion tracking system
#pharma
#digitalhealth
0
4
9
Novartis to buy gene therapy company AveXis for $8.7 billion $NVS $AVXS
0
4
8
FirstWord Lists – The biggest drug approvals of 2015
http://t.co/tXIJsV7my7
#pharma
#biotech
http://t.co/kF5BUtMQq0
0
30
8
BREAKING NEWS: AbbVie near deal to acquire Allergan for over $60 billion - report $ABBV $AGN
0
7
9
Merck & Co. enters deal with Skyhawk to develop small molecules that modulate RNA splicing $MRK
0
4
8
Pfizer identifies lead compound with antiviral activity against SARS-CoV-2
0
2
8
FDA APPROVES ASTRAZENECA'S KOSELUGO AS FIRST THERAPY FOR CHILDREN WITH NEUROFIBROMATOSIS TYPE 1
0
3
8
FirstWord Lists: Big
#pharma
,
#biotech
lead product dependency rates
http://t.co/Rhf1BdN5Bh
http://t.co/07nyh0HJN8
1
23
8
Phase III win for Roche's anti-TIGIT drug tempered by trial's comparator $RHHBY
0
1
7
Pfizer close to merging off-patent drug business with Mylan: report
0
1
9
Byondis' trastuzumab ADC hits main goal of Phase III breast cancer study
0
2
9
SANOFI TO DONATE 100 MILLION DOSES OF HYDROXYCHLOROQUINE TO 50 COUNTRIES IN RESPONSE TO COVID-19 PANDEMIC
1
4
8
Annual sales of Merck & Co.’s Keytruda pass $25 billion $MRK
0
1
9
BREAKING NEWS: First CRISPR therapy gains approval, with UK giving nod to Casgevy $VRTX $CRSP
1
3
9
AstraZeneca, Merck & Co.'s PARP inhibitor Lynparza gains FDA approval as maintenance treatment for pancreatic cancer $AZN $MRK
0
5
8
AbbVie's Skyrizi bests Novartis' Cosentyx in Phase III plaque psoriasis trial
0
4
9
Gilead's CAR-T cell therapy Yescarta gains clearance in Europe for lymphomas $GILD
0
7
7
FDA approves first
#biosimilar
for the treatment of cancer - Amgen's version of Avastin, called Mvasi - PR $AMGN
1
6
7
FDA expands Eli Lilly, Boehringer Ingelheim's Jardiance to improve survival in patients with type 2 diabetes
0
8
8
What factors make industry symposia valuable to
#HCPs
? New study reveals 81% of polled HCPs ranked quality of speakers as their main reason for attending
#medicalcongresses
Read More:
#firstwordperspectives
#ad
3
4
8
Padcev, Keytruda combo significantly improves survival in bladder cancer trial $SGEN $MRK
1
2
7
Sanofi, Regeneron launch clinical trial programme testing rheumatoid arthritis drug Kevzara to treat severe COVID-19
0
1
8
AstraZeneca, Merck & Co.'s Lynparza significantly delays disease progression as first-line maintenance therapy for ovarian cancer $AZN $MRK
0
3
8
J&J, Legend's Carvykti cuts risk of progression/death by 74% in myeloma study $JNJ $LEGN
0
3
7
Gilead, Merck & Co. to jointly develop long-acting HIV treatments $GILD $MRK
0
3
8
BREAKING NEWS: GSK expands vaccine portfolio with $3.3-billion deal for Affinivax $GSK
0
1
8
BREAKING NEWS: AbbVie in $10.1-billion deal to buy ImmunoGen $ABBV $IMGN
1
5
8
FDA okays first gene therapies for sickle-cell disease $VRTX $CRSP $BLUE
0
4
8
AstraZeneca targeting over 2 billion COVID-19 vaccine doses after latest deals
0
0
8
FDA approves Bayer, Merck & Co.'s Verquvo to treat chronic heart failure $BAY $MRK
0
2
7
CG Oncology aims for $1B valuation in race for year's first biotech IPO
0
4
8
#FDA
accepts Otsuka, Proteus Digital Health's filing for single tablet combining Abilify, ingestible sensor
http://t.co/cEHkNvXxq0
0
10
6
Novartis buys remaining rights to ofatumumab from GlaxoSmithKline for over $1 billion
http://t.co/radItie1Kt
$NVS $GSK
#pharma
0
8
6
BREAKING NEWS: Sanofi to buy Ablynx for 3.9 billion euros $SNY $ABLX
1
13
6
Gilead’s cell therapy unit Kite laying off 7% of staff $GILD
0
1
8
EMA recommends first COVID-19 vaccine for authorisation in the EU $PFE $BNTX
0
3
8
FDA clears Spark Therapeutics' gene therapy Luxturna for inherited form of retinal dystrophy $ONCE
#GeneTherapy
0
6
7
3
11
7
GSK pays €400M to take full control of mRNA-based jabs from CureVac $GSK $CVAC
0
2
7
J&J ends sales of opioids in the US, reaches settlement deal with New York $JNJ
0
2
7
GSK licenses preclinical T-cell engaging Abs from WuXi Biologics $GSK
0
2
7
Gilead inks non-US deals with five generic drugmakers to expand supply of COVID-19 drug remdesivir
0
1
7
Eli Lilly bolsters immuno-oncology pipeline with deal to buy ARMO BioSciences for $1.6 billion $LLY $ARMO
0
8
6
FDA clears Roche's multiple sclerosis therapy Ocrevus $RHHBY
0
2
6
Drugmakers getting "more sophisticated" at improving access to medicines, but more needed in area of affordability
0
6
7
Allergan unveils single-digit price increases for a number of branded drugs, in line with "social contract" $AGN
0
4
6
ADCs still attracting large pharma as Roche signs $1B partnership with MediLink $RHHBY $MLKNA
0
0
7
Gilead's CAR-T cell therapy Tecartus gains FDA approval for mantle cell lymphoma
0
2
7